بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان

Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurren...

Full description

Bibliographic Details
Main Authors: Nizal Sarrafzadegan, Sedigheh Asgari, Nafiseh Toghianifar, Mohammad Talaei, Aliakbar Tavassoli, Maryam Boshtam, Masoumeh Sadeghi
Format: Article
Language:fas
Published: Vesnu Publications 2011-03-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/833
id doaj-2e85e1c5ed20446786ef6903fba8526f
record_format Article
spelling doaj-2e85e1c5ed20446786ef6903fba8526f2020-11-25T01:05:14ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2011-03-012812419671977522بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهانNizal Sarrafzadegan0Sedigheh Asgari1Nafiseh Toghianifar2Mohammad Talaei3Aliakbar Tavassoli4Maryam Boshtam5Masoumeh Sadeghi6Professor, Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Pharmacognosist, Basic Sciences, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfa-han, Iran.General Practitioner, Quality Control Unit, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.General Practitioner, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Cardiologist, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.MSc in Physiology, Laboratory of Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurrence of cardiovascular disease events in a cohort study. Methods: A cohort study was performed on 5375 subjects aged ≥ 35 years old participating in the Isfahan Healthy Heart Program (IHHP) that had been recruited with multistage cluster random sampling method. Apo-A and apo-B were measured in all subjects while trans fatty acids were measured on a random sample of 238 subjects. The relative risk of these factors for CVD events was defined in a 6-year period. T-test was used to compare means. Logistic regression and Cox regression were used to calculate Hazard ratio of cardiovascular disease events. Finding: After adjustment for age and sex, the relative risk for cardiovascular disease events was 2.393 (95%CI 1.155-4.961) for apo-B/A, 1.007 (95%CI 1.004-1.009) for total cholesterol, 1.002 (95%CI 1.001-1.003) for triglycerides, and 1.008 (95%CI 1.005-1.010) for LDL-cholesterol. After adjustment for smoking, diabetes, hypertension, and obesity, the relative risk for total cholesterol (1.006, 95%CI 1.003-1.008) and LDL-cholesterol 1.007, 95%CI 1.004-1.010) was significant while insignificant for trans fatty acids. Conclusion: This study showed that relative risk of apo-B/A for cardiovascular disease events is similar to total cholesterol and LDL-cholesterol. However, after adjustment for other risk factors, the association remained significant only for total cholesterol and LDL-cholesterol. Trans fatty acids did not show significant risk for cardiovascular disease event.http://jims.mui.ac.ir/index.php/jims/article/view/833Cardiovascular diseaseApolipoproteinsTrans fatty acidsCohort studies
collection DOAJ
language fas
format Article
sources DOAJ
author Nizal Sarrafzadegan
Sedigheh Asgari
Nafiseh Toghianifar
Mohammad Talaei
Aliakbar Tavassoli
Maryam Boshtam
Masoumeh Sadeghi
spellingShingle Nizal Sarrafzadegan
Sedigheh Asgari
Nafiseh Toghianifar
Mohammad Talaei
Aliakbar Tavassoli
Maryam Boshtam
Masoumeh Sadeghi
بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
مجله دانشکده پزشکی اصفهان
Cardiovascular disease
Apolipoproteins
Trans fatty acids
Cohort studies
author_facet Nizal Sarrafzadegan
Sedigheh Asgari
Nafiseh Toghianifar
Mohammad Talaei
Aliakbar Tavassoli
Maryam Boshtam
Masoumeh Sadeghi
author_sort Nizal Sarrafzadegan
title بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
title_short بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
title_full بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
title_fullStr بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
title_full_unstemmed بررسی ارتباط آپولیپوپروتئین‌های A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
title_sort بررسی ارتباط آپولیپوپروتئین‌های a، b و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعه‌ی هم گروهی برنامه‌ی قلب سالم اصفهان
publisher Vesnu Publications
series مجله دانشکده پزشکی اصفهان
issn 1027-7595
1735-854X
publishDate 2011-03-01
description Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurrence of cardiovascular disease events in a cohort study. Methods: A cohort study was performed on 5375 subjects aged ≥ 35 years old participating in the Isfahan Healthy Heart Program (IHHP) that had been recruited with multistage cluster random sampling method. Apo-A and apo-B were measured in all subjects while trans fatty acids were measured on a random sample of 238 subjects. The relative risk of these factors for CVD events was defined in a 6-year period. T-test was used to compare means. Logistic regression and Cox regression were used to calculate Hazard ratio of cardiovascular disease events. Finding: After adjustment for age and sex, the relative risk for cardiovascular disease events was 2.393 (95%CI 1.155-4.961) for apo-B/A, 1.007 (95%CI 1.004-1.009) for total cholesterol, 1.002 (95%CI 1.001-1.003) for triglycerides, and 1.008 (95%CI 1.005-1.010) for LDL-cholesterol. After adjustment for smoking, diabetes, hypertension, and obesity, the relative risk for total cholesterol (1.006, 95%CI 1.003-1.008) and LDL-cholesterol 1.007, 95%CI 1.004-1.010) was significant while insignificant for trans fatty acids. Conclusion: This study showed that relative risk of apo-B/A for cardiovascular disease events is similar to total cholesterol and LDL-cholesterol. However, after adjustment for other risk factors, the association remained significant only for total cholesterol and LDL-cholesterol. Trans fatty acids did not show significant risk for cardiovascular disease event.
topic Cardiovascular disease
Apolipoproteins
Trans fatty acids
Cohort studies
url http://jims.mui.ac.ir/index.php/jims/article/view/833
work_keys_str_mv AT nizalsarrafzadegan brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT sedighehasgari brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT nafisehtoghianifar brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT mohammadtalaei brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT aliakbartavassoli brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT maryamboshtam brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
AT masoumehsadeghi brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn
_version_ 1725195439436726272